Dr. Scott Connelly has devoted his life to the science of nutrition and fitness, and is considered around the world as a leading expert in the field of human nutrition and metabolism. Dr. Connelly has distinguished his career both academically and clinically as a researcher and practitioner of advanced human metabolism in the operating room and the intensive care units of both Massachusetts General Hospital and Stanford University Hospital. He is regarded by nutrition industry professionals and distinguished clinicians as a pioneer in the application of dairy bioactives in exercise science and clinical medicine.
During his residency at Harvard Medical School's prestigious Massachusetts General Hospital, Dr. Connelly began his research efforts involving protein metabolism by working with critically ill intensive care patients. In order to promote his patients' survival in the face of unrelenting losses of lean body mass, he began researching and formulating products to help prevent the loss of muscle mass. What he learned about the effects of nutrients and exercise on human metabolism, body composition, disease prevention and immune system function, however, would soon have more far reaching impact.
While continuing his research as a Senior Fellow in intensive care medicine at Stanford University, Dr. Connelly created a high quality protein formulation, which he trademarked Metamyosyn. This became the key ingredient in MET-Rx, the first commercial product in history with demonstrated potent biological activity to accelerate the growth of skeletal muscle in humans.
The MET-Rx formulation took Dr. Connelly over twenty years to develop, and as a result of a landmark study published in the Journal of Burn Care and Rehabilitation revealing that MET-Rx doubled the lean body mass weight gain of severe burn patients in the critical acute recovery phase of their injury resulting in increased strength, mobility, and wound healing leading to reduced hospital stays by as much as 30%.
First and foremost, Dr. Connelly is a physician whose goal is to improve the quality of life through superior nutrition for both the healthiest and sickest people. Dr. Connelly's work is respected by health care providers, top athletes, Hollywood celebrities, and fitness enthusiasts worldwide.
Expanding his involvement in public health, Dr. Connelly is the namesake of UCLA's Connelly Laboratory for Applied Nutritional Sciences at the UCLA School of Medicine, Division of Clinical Nutrition and the founder of the Connelly Foundation, a private charity devoted to supporting applied nutritional sciences.
After the sale of the Met-Rx companies in 2000 Dr. Connelly authored the best seller "Body Rx" and partnered with two visionary companies in the dairy science and biotechnology fields to collaborate on the commercialization of an array of extremely potent biologically active molecules. The first products reaching marketplace are branded under the name Progenex.
http://www.progenexsrg.com/
Science will be the foundation of all future societies. Technological progress is exponential and is increasing at an exponential rate. In time all the questions in the Universe will be answered by science. Technological evolution is the extension of human evolution. thinkersbebo. com has been born from these mindsets.
doc,can't ever thank you enough for bringing the absolute best innovative supplements to us!!your brilliant contributions and inspiring motivational qualities continue. all the best with progenex!!rob
Dr. Scott Connelly has devoted his life to the science of nutrition and fitness, and is considered around the world as a leading expert in the field of human nutrition and metabolism. Dr. Connelly has distinguished his career both academically and clinically as a researcher and practitioner of advanced human metabolism in the operating room and the intensive care units of both Massachusetts General Hospital and Stanford University Hospital. He is regarded by nutrition industry professionals and distinguished clinicians as a pioneer in the application of dairy bioactives in exercise science and clinical medicine.
During his residency at Harvard Medical School's prestigious Massachusetts General Hospital, Dr. Connelly began his research efforts involving protein metabolism by working with critically ill intensive care patients. In order to promote his patients' survival in the face of unrelenting losses of lean body mass, he began researching and formulating products to help prevent the loss of muscle mass. What he learned about the effects of nutrients and exercise on human metabolism, body composition, disease prevention and immune system function, however, would soon have more far reaching impact.
While continuing his research as a Senior Fellow in intensive care medicine at Stanford University, Dr. Connelly created a high quality protein formulation, which he trademarked Metamyosyn. This became the key ingredient in MET-Rx, the first commercial product in history with demonstrated potent biological activity to accelerate the growth of skeletal muscle in humans.
The MET-Rx formulation took Dr. Connelly over twenty years to develop, and as a result of a landmark study published in the Journal of Burn Care and Rehabilitation revealing that MET-Rx doubled the lean body mass weight gain of severe burn patients in the critical acute recovery phase of their injury resulting in increased strength, mobility, and wound healing leading to reduced hospital stays by as much as 30%.
First and foremost, Dr. Connelly is a physician whose goal is to improve the quality of life through superior nutrition for both the healthiest and sickest people. Dr. Connelly's work is respected by health care providers, top athletes, Hollywood celebrities, and fitness enthusiasts worldwide.
Expanding his involvement in public health, Dr. Connelly is the namesake of UCLA's Connelly Laboratory for Applied Nutritional Sciences at the UCLA School of Medicine, Division of Clinical Nutrition and the founder of the Connelly Foundation, a private charity devoted to supporting applied nutritional sciences.
After the sale of the Met-Rx companies in 2000 Dr. Connelly authored the best seller "Body Rx" and partnered with two visionary companies in the dairy science and biotechnology fields to collaborate on the commercialization of an array of extremely potent biologically active molecules. The first products reaching marketplace are branded under the name Progenex.
